Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 31, 2015
Radiopeptides for Imaging and Therapy: A Radiant FutureKristell L S Chatalic, Dik J Kwekkeboom, Marion de JongJournal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 16, 2015
A Novel ¹¹¹In-Labeled Anti-Prostate-Specific Membrane Antigen Nanobody for Targeted SPECT/CT Imaging of Prostate CancerKristell L S Chatalic, Joke Veldhoven-Zweistra, Michiel Bolkestein, et al.Journal of Personalized Medicine|April 30, 2021
Nuclear Medicine Imaging in Neuroblastoma: Current Status and New DevelopmentsAtia Samim, Godelieve A M Tytgat, Gitta Bleeker, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 22, 2014
Preclinical comparison of Al18F- and 68Ga-labeled gastrin-releasing peptide receptor antagonists for PET imaging of prostate cancerKristell L S Chatalic, Gerben M Franssen, Wytske M van Weerden, et al.European Journal of Medicinal Chemistry|March 20, 2012
Synthesis, modeling and functional activity of substituted styrene-amides as small-molecule CXCR7 agonistsMaikel Wijtmans, David Maussang, Francesco Sirci, et al.Theranostics|May 11, 2016
Towards Personalized Treatment of Prostate Cancer: PSMA I&T, a Promising Prostate-Specific Membrane Antigen-Targeted Theranostic AgentKristell L S Chatalic, Sandra Heskamp, Mark Konijnenberg, et al.Theranostics|January 2, 2016
In Vivo Stabilization of a Gastrin-Releasing Peptide Receptor Antagonist Enhances PET Imaging and Radionuclide Therapy of Prostate Cancer in Preclinical StudiesKristell L S Chatalic, Mark Konijnenberg, Julie Nonnekens, et al.Cancer Biotherapy & Radiopharmaceuticals|March 17, 2017
<sup>213</sup>Bi-Labeled Prostate-Specific Membrane Antigen-Targeting Agents Induce DNA Double-Strand Breaks in Prostate Cancer XenograftsJulie Nonnekens, Kristell L S Chatalic, Janneke D M Molkenboer-Kuenen, et al.Pageof 1